Guideline Emphasis on Earlier Treatment to Reduce Health, Dementia Risks Boosts Urgency to Keep Closer Watch on Blood Pressure
OMRON innovations support 2025 guidelines on heart-brain connection, close blood pressure management throughout pregnancy, and healthy lifestyle behaviors
HOFFMAN ESTATES, Ill., Aug. 19, 2025 /PRNewswire/ — Heart health leader OMRON Healthcare today issued a national call-to-action for regular at-home blood pressure monitoring in response to new guidelines by the American Heart Association (AHA) and American College of Cardiology (ACC). The first new set of guidelines since 2017 emphasize earlier detection and treatment of high blood pressure for all Americans – making regular at-home blood pressure monitoring an essential daily health practice.
“Half of all U.S. adults have high blood pressure, which is the number one preventable risk factor for heart attack, stroke, heart failure, and cognitive decline,” said Jim Li, executive director, global medical affairs at OMRON Healthcare. “The 2025 guidelines make one thing clear: don’t wait for your next doctor’s visit. Regular blood pressure monitoring at home is an important practice for long-term good health.”
The new AHA/ACC guidelines incorporate a decade of research on blood pressure, from 2015 to 2024, and emphasize the importance of a healthy lifestyle and early intervention of high blood pressure to reduce the risk of heart disease, kidney disease, type 2 diabetes, and dementia.
“The first new guidelines in eight years bring major changes to how we should view blood pressure and the urgency to make routine monitoring a priority as a bridge to earlier treatment,” said OMRON Healthcare U.S. Managing Director Alice Koehler. “The guidelines spotlight the heart-brain connection and higher dementia risks from uncontrolled blood pressure. There is more urgency to keep closer watch on blood pressure before, during and after pregnancy to prevent long-term health damage to moms and babies.”
OMRON Healthcare issued the following recommended actions based on the new AHA/ACC blood pressure guidelines:
“The new guidelines are a call to action for earlier detection and proactive blood pressure management for overall good health,” said Koehler. “OMRON innovations – from our advanced blood pressure monitors and Intellisense AFib detection to the OMRON connect app – are accessible, affordable, and designed to support medical professionals and patients of all ages.”
For more information on blood pressure monitoring, AFib detection, and healthy lifestyle behaviors, visit OmronHealthcare.com.
About OMRON Healthcare, Inc.
OMRON Healthcare, Inc., is the world’s leading manufacturer and distributor of personal heart health products and an innovator in technologies supporting respiratory and pain management care. With over 50 years of medical device category leadership, OMRON is passionate about empowering people to take charge of their health at home through precise technology. Its market-leading products include a full range of home blood pressure monitors, nebulizers and TENS devices. The company’s mission is Going for Zero, the elimination of heart attacks and strokes. With more than 350 million devices sold globally, OMRON provides the world’s most recommended blood pressure monitors by healthcare professionals. OMRON Healthcare strives to improve lives and contribute to a better society by developing innovations that help people prevent, treat, and manage their medical conditions. The company provides products and services in over 130 countries. For more information, visit OmronHealthcare.com.
SOURCE OMRON Healthcare
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…
Mississauga, Ontario--(Newsfile Corp. - December 5, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), announced…
Atropos Health is integrating the American Society of Clinical Oncology® (ASCO®) Guidelines into their platform…
PLANO, Texas, Dec. 5, 2025 /PRNewswire/ -- Teams playing in the StaffDNA® Cure Bowl were…
IRVINE, Calif., Dec. 5, 2025 /PRNewswire/ -- The Dot Corp has expanded its services with…